Literature DB >> 2945558

Atrial natriuretic peptide mRNA is regulated by glucocorticoids in vivo.

D G Gardner, S Hane, D Trachewsky, D Schenk, J D Baxter.   

Abstract

In these studies glucocorticoids were found to increase the plasma levels of atrial natriuretic peptide (ANP) as well as the expression of the ANP gene in the Sprague-Dawley rat. Plasma ANP rose two-fold after 48 hrs. of exposure to dexamethasone (1 mg/day) in both intact and adrenalectomized animals. This was accompanied by a 1.5-2.0 fold increase in the levels of atrial and ventricular ANP transcripts. Deoxycorticosterone acetate (5 mg/day), administered on the same schedule, failed to increase either plasma ANP levels or cardiac ANP mRNA accumulation. These effects suggest that ANP may have a potential role as a mediator of glucocorticoid activity in the cardiovascular system and support the hypothesis that ANP is a glucocorticoid-regulated gene.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2945558     DOI: 10.1016/s0006-291x(86)80283-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Cis-acting sequences that modulate atrial natriuretic factor gene expression.

Authors:  C E Seidman; D W Wong; J A Jarcho; K D Bloch; J G Seidman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

2.  Atrial natriuretic peptide in Cushing's disease.

Authors:  G Opocher; S Rocco; G Carpenè; F Pedini; M Scarante; R Milani; M Boscaro; F Mantero
Journal:  J Endocrinol Invest       Date:  1990-02       Impact factor: 4.256

3.  Atrial natriuretic peptide response to endurance physical training in the rat.

Authors:  J Ibanez; G Gauquelin; D Desplanches; H Y Qiu; Y Dalmaz; J Fareh; C Gharib
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1990

4.  Cerebral haemodynamics in preterm infants after exposure to dexamethasone.

Authors:  A Pellicer; F Gayá; T A Stiris; J Quero; F Cabañas
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-09       Impact factor: 5.747

5.  Plasma concentration of human atrial natriuretic hormone in patients with connective tissue diseases.

Authors:  M Yasuda; D Yasuda; K Tomooka; M Nobunaga
Journal:  Clin Rheumatol       Date:  1993-06       Impact factor: 2.980

6.  Divergent regulation of the human atrial natriuretic peptide gene by c-jun and c-fos.

Authors:  B Kovacic-Milivojević; D G Gardner
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

7.  Exercise increases the release of atrial natriuretic peptide in heart transplant recipients.

Authors:  J Pepke-Zaba; T W Higenbottam; A Morice; A T Dinh-Xuan; A E Raine; J Wallwork
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

8.  Distribution of atrial natriuretic peptide in the conduction system and ventricular muscles of the human heart.

Authors:  N Mochizuki; H Sawa; H Yasuda; T Shinohara; K Nagashima; T Yamaji; N Ohnuma; W W Hall
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

9.  Effect of phorbol ester on the release of atrial natriuretic peptide from the hypertrophied rat myocardium.

Authors:  P Kinnunen; T Taskinen; M Järvinen; H Ruskoaho
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

10.  Mechanisms of hypertension during and after orthotopic liver transplantation in children.

Authors:  S Lawless; D Ellis; A Thompson; D R Cook; C Esquivel; T Starzl
Journal:  J Pediatr       Date:  1989-09       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.